Early Results For Therapyx/Intravacc's Vaccine May Herald Progress In Gonorrhea Prevention
SBIR Award Received From The US NIAID
Executive Summary
Therapyx and Intravacc are optimizing a candidate gonorrhea vaccine following promising results in primates and the granting of a three-year SBIR award by the US NIAID.